Table 1.
Overall | Hepatocellular Carcinoma Due to Hepatitis B | Hepatocellular Carcinoma Due to Hepatitis C | Hepatocellular Carcinoma Due to Alcohol Use | Hepatocellular Carcinoma Due to NASH | Hepatocellular Carcinoma Due to Other Cause | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Incidence Cases (95% UI) | ASIR Per 100,000 (95% UI) | Incidence Cases (95% UI) | ASIR Per 100,000 (95% UI) | Incidence Cases (95% UI) | ASIR Per 100,000 (95% UI) | Incidence Cases (95% UI) | ASIR Per 100,000 (95% UI) | Incidence Cases (95% UI) | ASIR Per 100,000 (95% UI) | Incidence Cases (95% UI) | ASIR Per 100,000 (95% UI) | |
Both | 96,434.35 (80,970.60, 113,768.66) | 10.58 (8.94, 12.43) | 63,118.39 (52,017.87, 75,226.51) | 6.58 (5.45, 7.84) | 14,422.25 (11,688.21, 17,539.40) | 1.94 (1.57, 2.32) | 7499.99 (5772.02, 9563.40) | 0.84 (0.66, 1.07) | 4056.85 (3237.49, 4977.60) | 0.48 (0.38, 0.58) | 5067.76 (4016.85, 6304.76) | 0.54 (0.43, 0.66) |
Femlae | 26,225.22 (20,940.93, 31,755.09) | 6.04 (4.82, 7.28) | 9910.86 (7731.49, 12,322.23) | 2.14 (1.67, 2.66) | 8268.76 (6411.30, 10,161.78) | 2.13 (1.66, 2.61) | 2591.40 (1924.27, 3344.60) | 0.59 (0.43, 0.75) | 1931.27 (1465.97, 2400.29) | 0.45 (0.34, 0.55) | 2474.93 (1859.22, 3162.47) | 0.53 (0.40, 0.67) |
Male | 70,209.13 (56,752.31, 85,768.18) | 15.06 (12.20, 18.24) | 53,207.53 (42,644.94, 65,059.04) | 11.01 (8.88, 13.40) | 6153.49 (4661.25, 7878.17) | 1.68 (1.31, 2.09) | 4908.59 (3691.89, 6547.27) | 1.12 (0.84, 1.45) | 2125.58 (1631.29, 2729.53) | 0.50 (0.39, 0.64) | 2592.83 (2001.92, 3354.05) | 0.54 (0.42, 0.69) |
UI: uncertainty interval; NASH: Non-alcoholic steatohepatitis; ASIR: age-standardized incidence rate.